category

Earnings Report

Merck's 4Q Revenue Falls Short

Merck's quarterly revenue narrowly missed Wall Street expectations, hurt by lower-than-expected sales of its key immuno-oncology drug, Keytruda, and its diabetes medicines.

Merck's 4Q Revenue Falls Short

Merck's quarterly revenue narrowly missed Wall Street expectations, hurt by lower-than-expected sales of its key immuno-oncology drug, Keytruda, and its diabetes medicines.

Cigna's Profit Beats Estimates

Cigna, which is awaiting a ruling on the U.S. government's lawsuit to block its acquisition by Anthem, reported a better-than-expected quarterly profit, helped by strength in its commercial business.

Cigna's Profit Beats Estimates

Cigna, which is awaiting a ruling on the U.S. government's lawsuit to block its acquisition by Anthem, reported a better-than-expected quarterly profit, helped by strength in its commercial business.

Shell Misses Fourth-Quarter Estimates

Royal Dutch Shell's profits were lower than forecast in the last quarter of 2016 due to an unexpected charge relating to foreign exchange moves, but it was still ahead of its larger U.S. rival Exxon Mobil.

Shell Misses Fourth-Quarter Estimates

Royal Dutch Shell's profits were lower than forecast in the last quarter of 2016 due to an unexpected charge relating to foreign exchange moves, but it was still ahead of its larger U.S. rival Exxon Mobil.